Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BeOne Medicines (BEIGF) Return on Assets (2016 - 2025)

BeOne Medicines (BEIGF) has disclosed Return on Assets for 10 consecutive years, with 0.04% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 15.0% to 0.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.04% through Dec 2025, up 15.0% year-over-year, with the annual reading at 0.04% for FY2025, 15.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.04% at BeOne Medicines, up from 0.01% in the prior quarter.
  • The five-year high for Return on Assets was 0.04% in Q4 2025, with the low at 0.34% in Q1 2023.
  • Average Return on Assets over 5 years is 0.18%, with a median of 0.19% recorded in 2021.
  • The sharpest move saw Return on Assets fell -12bps in 2022, then rose 20bps in 2024.
  • Over 5 years, Return on Assets stood at 0.21% in 2021, then crashed by -57bps to 0.33% in 2022, then skyrocketed by 53bps to 0.16% in 2023, then rose by 29bps to 0.11% in 2024, then skyrocketed by 133bps to 0.04% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.04%, 0.01%, and 0.03% for Q4 2025, Q3 2025, and Q2 2025 respectively.